Argus Research Keeps Their Buy Rating on Healthpeak Properties (DOC)
Healthpeak Properties Analyst Ratings
BNP Paribas Adjusts Price Target on Healthpeak Properties to $21 From $19
Buy Rating Affirmed for Healthpeak Properties Amid Strong Q1 Performance and Raised Financial Guidance
Healthpeak Properties Analyst Ratings
Healthpeak Properties Analyst Ratings
Analysts Offer Insights on Real Estate Companies: Healthpeak Properties (DOC) and CoStar Group (CSGP)
Scotiabank Keeps Their Buy Rating on Healthpeak Properties (DOC)
Healthpeak Properties Gets Double-upgrade at BofA on NOI Growth Prospects
Healthpeak Properties Analyst Ratings
Healthpeak Properties Analyst Ratings
Analysts Offer Insights on Real Estate Companies: Healthpeak Properties (DOC), Uniti Group (UNIT) and CoStar Group (CSGP)
Analysts' Top Real Estate Picks: Simon Property (SPG), Healthpeak Properties (DOC)
Healthpeak Properties Analyst Ratings
Healthpeak Properties Analyst Ratings
Stifel Nicolaus Sticks to Its Buy Rating for Healthpeak Properties (PEAK)
Healthpeak Properties Analyst Ratings
Scotiabank Upgrades Healthpeak Properties to Sector Outperform, Announces $23 Price Target
Healthpeak Properties Analyst Ratings
Analysts Offer Insights on Real Estate Companies: AG Mortgage (MITT), Healthpeak Properties (PEAK) and Equinix (EQIX)
No Data